Successes and risks of gene therapy in primary immunodeficiencies
Open Access
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 113 (4) , 595-603
- https://doi.org/10.1016/j.jaci.2004.01.765
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Effect of CD3δ Deficiency on Maturation of α/β and γ/δ T-Cell Lineages in Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Primary immunodeficiency diseases: an updateClinical and Experimental Immunology, 2003
- Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99The Lancet, 2003
- Primary immunodeficiency diseases: dissectors of the immune systemImmunological Reviews, 2002
- Mutations in the RNA Component of RNase MRP Cause a Pleiotropic Human Disease, Cartilage-Hair HypoplasiaPublished by Elsevier ,2001
- Exposing the human nude phenotypeNature, 1999
- Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1999
- Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infantsThe Journal of Pediatrics, 1997
- Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cellsBlood, 1983
- IMMUNOLOGICAL RECONSTITUTION OF SEX-LINKED LYMPHOPENIC IMMUNOLOGICAL DEFICIENCYThe Lancet, 1968